Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. [electronic resource]
Producer: 20131126Description: e61165 p. digitalISSN:- 1932-6203
- Animals
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Fibrinolysis -- drug effects
- Mice
- Mice, Inbred C57BL
- Neovascularization, Pathologic -- drug therapy
- Peritoneal Dialysis -- adverse effects
- Peritoneum -- blood supply
- Phenotype
- Tamoxifen -- pharmacology
- Transforming Growth Factor beta1 -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.